Patent · US Active

Formulations containing a somatostatin receptor agonist

US11135264B2 · kind B2 · utility

1Cited by

3References

32Claims

0Family size

Assignee

CAMURUS AB · SE

Inventors

Justas Barauskas · Lund, SE
Catalin Nistor · Lund, SE
Markus Johnsson · Lund, SE

Key dates

Filing date	Jun 22, 2020
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Jun 22, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pre-formulations comprising: The invention further relates to methods of treatment comprising administration of such pre-formulations, to pre-filled administration devices and kits containing the formulations, to the use of an alkylammonium EDTA salt to reduce the decomposition of the lipid components and/or any active agent contained within the pre-formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.